MannKind
Price & Volume
Stats
See more52W Range | $2.23-$6.51 |
Market Cap | $1B |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $360.7M |
Revenue Growth (YoY) | 15.1% |
Gross Profit (12 Mos) | $272.8M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 18 hours ago
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval
Yahoo Finance • 20 hours ago
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
Yahoo Finance • 19 days ago
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
Yahoo Finance • last month
How The MannKind (MNKD) Story Is Shifting With Tyvaso DPI And Soft Mist Uncertainty
About
CEO | Dr. Michael E. Castagna Pharm.D. |
Address | 1 Casper Street, Danbury, CT, United States, 06810 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 591 |